HAEMONETICS CORP MASS - NOTE 3/0

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Debt / NOTE 3/0
Market price (% of par)
85.05%
Total 13F principal
$468,923,009
Principal change
+$30,598,911
Total reported market value
$399,453,244
Number of holders
46
Value change
+$26,559,166
Number of buys
16
Number of sells
17

Institutional Holders of HAEMONETICS CORP MASS - NOTE 3/0 as of Q1 2023

As of 31 Mar 2023, HAEMONETICS CORP MASS - NOTE 3/0 was held by 46 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $468,923,009 in principal (par value) of the bond. The largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, FRANKLIN RESOURCES INC, Kohlberg Kravis Roberts & Co. L.P., Wellesley Asset Management, AVIVA PLC, OAKTREE CAPITAL MANAGEMENT LP, Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, DeepCurrents Investment Group LLC, and Aequim Alternative Investments LP. This page lists 46 institutional bondholders reporting positions for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.